InvestorsHub Logo
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 664

Wednesday, 10/21/2020 9:55:56 AM

Wednesday, October 21, 2020 9:55:56 AM

Post# of 803
ABT 3Q20 Results by Business Segment


%Corp YoY Growth
Segment Sales (const currency)

Medical devices* 36% +3%
Diagnostics 30% +39%
Nutrition 22% +4%
Drugs† 12% -3%

COVID-19 testing boosted the diagnostics segment, while the medical-devices segment bounced back from a COVID-related dip in 2Q20.

62% of overall sales were ex-US.

*Includes diabetes care.
†Branded generics in emerging markets.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News